AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET ANALYSIS
Increasing number of multidrug resistance cases in tuberculosis (TB), malaria, HIV, influenza, and others among the global population is expected to result in increasing adoption of antimicrobial susceptibility testing to reduce the resistance exposure during the forecast period. For instance, according to the World Health Organization (WHO), in 2014, there were around 480,000 new cases of multidrug-resistant tuberculosis (MDR-TB), a form of tuberculosis that is resistant to the two most powerful anti-TB drugs. Among these, only around 123,000 cases were detected and reported.
Moreover, increasing number of product launches is also expected to highly contribute to the automated antimicrobial susceptibility testing market growth. For instance, in March 2016, Becton, Dickinson and Company launched the new BD Phoenix M50 ID/AST system, which helps to deliver the same rapid, accurate, and cost-effective testing as the legacy BD Phoenix 100, within a small footprint.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowPress Release
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India :